Can Intra-Cellular (ITCI) Climb 33% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 11/23/22
Intra-Cellular's (ITCI) Caplyta Aids Growth, Overdependence a WoeZacks Investment Research • 11/18/22
How Much Upside is Left in Intra-Cellular (ITCI)? Wall Street Analysts Think 33%Zacks Investment Research • 11/07/22
Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/03/22
Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call and WebcastGlobeNewsWire • 10/27/22
Here's Why You Should Add Intra-Cellular Therapeutics (ITCI) Stock NowZacks Investment Research • 10/17/22
Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22
Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/09/22
Is a Surprise Coming for Intra-Cellular (ITCI) This Earnings Season?Zacks Investment Research • 08/08/22
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Intra-Cellular Therapies, Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 08/04/22
Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call and WebcastGlobeNewsWire • 08/02/22
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Intra-Cellular Therapies, Inc. with Losses to Contact the FirmNewsfile Corp • 06/24/22
Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/10/22
Analysts Estimate Intra-Cellular Therapies (ITCI) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/02/22